| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |